BOOST Pharma ApS: Financial statements 2024
CVR: 41120495
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BOOST Pharma ApS (CVR 41120495) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -2,193,394 and a net result of DKK -4,259,583 compared with DKK -2,753,145 the year before. Equity in the 2024 report amounted to DKK -7,039,565. The company had 2 employees in the financial year.
- Gross Profit
- DKK -2,193,394
- Profit/Loss
- DKK -4,259,583
- Equity
- DKK -7,039,565
- Total Assets
- DKK 7,625,284
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -2.2 mio. | -4.3 mio. | -7 mio. | 2 |
| 2023 | - | -1.5 mio. | -2.8 mio. | -9.2 mio. | 1 |
| 2022 | - | -3.5 mio. | -4.2 mio. | -6.4 mio. | 1 |
| 2021 | - | -1.3 mio. | -2.2 mio. | -2.2 mio. | 1 |
| 2020 | - | -21 t. | -63 t. | -23 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of October 1, 2024, Ingelise Saunders is registered as adm. dir. of BOOST Pharma ApS.
As of September 30, 2024, Everhardus Johannes Joseph Kueppers has stepped down as director of BOOST Pharma ApS.
As of August 26, 2024, Jonathan Jossi Ilicki has joined the board of directors of BOOST Pharma ApS.
As of August 26, 2024, Jonas Jendi has left the board of directors of BOOST Pharma ApS.
BOOST Pharma ApS has published its annual report for 2023. Gross profit came to DKK -1,529,771, and the net result was DKK -2,753,145.
As of June 25, 2024, Jonas Jendi has joined the board of directors of BOOST Pharma ApS.
As of June 25, 2024, Jonathan Jossi Ilicki has left the board of directors of BOOST Pharma ApS.
As of June 1, 2024, Everhardus Johannes Joseph Kueppers is registered as director of BOOST Pharma ApS.
As of June 1, 2024, Ingelise Saunders has stepped down as director of BOOST Pharma ApS.
As of May 23, 2024, Jonathan Jossi Ilicki has joined the board of directors of BOOST Pharma ApS.
About BOOST Pharma ApS
BOOST Pharma ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans Thalsgård Schambye. The company is owned by BOOST Pharma AB. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK -7,557,572 and a net result of DKK -9,243,488 compared with DKK -4,259,583 the year before. Equity in the 2025 report amounted to DKK -11,850,535.